Failure to control acute variceal bleeding is a strong predictor of mortality in patients with cirrhosis. Various criteria have been proposed to define failure to control bleeding for use as end points in randomized clinical trials. However, the clinical applicability and validation of these proposed criteria remain unresolved issues.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
de Franchis, R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J. Hepatol. 33, 846–852 (2000).
de Franchis, R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol. 43, 167–176 (2005).
de Franchis, R. et al. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol. 53, 762–768 (2010).
Thabut, D. et al. A multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhotic patients with variceal bleeding. Hepatology http://dx.doi.org/10.1002/hep.27407.
Thabut, D. et al. Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: analysis of the F7 liver-1288 study population. J. Hepatol. 53, 1029–1034 (2010).
Ahn, S. Y. et al. Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension. Hepatology http://dx.doi.org/10.1002/hep.27441.
Villanueva, C. et al. Transfusion strategies for acute upper gastrointestinal bleeding. N. Engl. J. Med. 368, 11–21 (2013).
Bosch, J. et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial. Hepatology 47, 1604–1614 (2008).
Seo, Y. S. et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology 60, 954–963 (2014).
Ripoll, C. et al. Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study. Hepatology 58, 2079–2088 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Hernández-Gea, V., García-Pagan, J. Can we identify failure to control acute variceal bleeding?. Nat Rev Gastroenterol Hepatol 11, 705–706 (2014). https://doi.org/10.1038/nrgastro.2014.178
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2014.178
